Bioavailability of prednisolone tabletsAubrey V. Tembo; Margarette R. Hallmark; Ermelinda Sakmar; Hannelore G. Bachmaan; Donald J. Weidler; John G. Wagner · 1977

Aspergillus nigermutants with increased glucose oxidase productionJohn Markwell; Laura G. Frakes; Eugene C. Brott; John Osterman; Fred W. Wagner · 1989

NEWS NOTESArt Smith, "Clancy" Flaten, Pete Putnam, Bob Wagner, Frank Neusbaum, Bill Clifford, G. Williams, John Ross Winnie, Anson C. Moorhouse, Pete Stallings, John Mercer, Charles N. Pockman, Bill Blume, Ed Oglesby and Herman Engel · Journal of the University Film Producers Association · 1950

Letters to the Editor:Fred J. Borch, Richard J. Hughes, William L. Guy, John A. Burns, John J. Mckeithen, Warren P. Knowles, Edmund G. Brown, Grant Sawyer, John Dempsey, Miriam K. Ringo, Albert Alexander, Paul Alpert, Overton H. Taylor, H. Peter Gray, Charles E. Wagner, Wilson R. Armstrong, George H. Phillips and Alfred Morris · Challenge · 1966

In VitroandIn Vivoavailability of some commercial prednisolone tabletsTimothy J. Sullivan; Roger G. Stoll; Ermelinda Sakmar; Donald C. Blair; John G. Wagner · 1974

In vitroandin vivoavailability of some commercial prednisolone tabletsTimothy J. Sullivan; Roger G. Stoll; Ermelinda Sakmar; Donald C. Blair; John G. Wagner · 1974

The Supreme Court of California 1974-1975John G. Fleming, Chuck Adams, Mary B. Seyferth, Kathleen M. Kelly, Andrew H. Sawyer, Lewis A. Kornhauser, Nena Manley, John Robertson, Thomas G. Quinn, George A. Juarez, Elisabeth A. Werby, Craig N. Oren, Fred Friedman, Lawrence A. Hobel, Charles F. Gorder, Jr., Coraltha Lewis, Phil Peters, Edward T. Marshall, H. Steven Durrett, Paul G. Rosengren, Margaret S. Smith, Izetta Ray Jackson, James L. Miller, Peter L. Shaw, Franklin A. Gevurtz and Arne Wagner · California Law Review · 1976

Types of mean residence timesDr. John G. Wagner · 1988

Introduction to PharmacoepidemiologyHartzema, Abraham G.; Porta, Miquel S.; Tilson, Hugh H. · Drug Intelligence & Clinical Pharmacy · 1987

American College of Clinical PharmacyDrug Intelligence & Clinical Pharmacy · 1979

Drug Information Analysis ServiceHart, Linda L.; Mowers, Robert M.; Dole, Ernie; Wells, Barbara G. · Drug Intelligence & Clinical Pharmacy · 1987

Adverse Reactions of PiroxicamD'Arcy, P. F.; Gerber, Dewald · Drug Intelligence & Clinical Pharmacy · 1987

Lidocaine serum concentrations following endoscopyFazio, Anthony; Patton, Lynn R.; Karpowicz, Frank; Pellecchia, Crescens · Drug Intelligence & Clinical Pharmacy · 1987

New Zinc Salt in DermatologyReiss, Daniel; Piriou, Alain; Boulard, Marc; Guillard, Oliver · Drug Intelligence & Clinical Pharmacy · 1979

Pyrazolone Derivatives (Antipyrine, Aminopyrine, Phenylbutazone, Oxyphenbutazone)Hartshorn, Edward A. · Drug Intelligence & Clinical Pharmacy · 1972

Using the Patient Drug ProfileSmith, William E. · Drug Intelligence & Clinical Pharmacy · 1970